Results 1 to 10 of about 867,189 (360)

Corrigendum to "A malignant symbiosis: The neuro-metabolic symphony rewires the tumor microenvironment" [Neoplasia 78 (2026) 101322]. [PDF]

Neoplasia
Zhang Z, Jia Y, Liu T, Wang S, Liu L.
europepmc   +1 more source

Epicutaneous immunotherapy

Allergologia et Immunopathologia, 2017
S, Scheurer, M, Toda
openaire   +2 more sources

Organ preservation after neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer: response assessment, watch-and-wait, and salvage surgery. [PDF]

Front Oncol
Yao N, Xu G, Duan N, Han F, Li W, Qu J.
europepmc   +1 more source

Adjuvant Atezolizumab for Stage III Deficient Mismatch Repair Colon Cancer-Its Impact on Clinical Practice. [PDF]

MedComm (2020)
Wu Y, Weng S, Yuan Y.
europepmc   +1 more source

Circulating tumor DNA in lung cancer immunotherapy: prognostic marker today, predictive tool tomorrow? [PDF]

Front Immunol
Li Y, Lu G, Song W, Lu J, Liu X, Cui J.
europepmc   +1 more source

HDAC2 restrains IGF2BP1-associated m6A dysregulation in cervical cancer immunotherapy resistance. [PDF]

PLoS One
Deng Q, Wang Z, Zhao J, Li N, Zhang L, He W, Zhang Y.   +6 more
europepmc   +1 more source

Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition. [PDF]

iScience
Botta GP, Edwards W, Nishizaki D, Hargreaves DC, Kato S, Kurzrock R.   +5 more
europepmc   +1 more source

The Evolving Role of Immunotherapy in the Treatment with Curative Purpose of Early, Intermediate and Advanced Stage Hepatocellular Carcinoma. [PDF]

Curr Oncol
Karampa AD, Goussia A, Baltagiannis EG, Anastasopoulos NT, Christodoulou DK, Glantzounis GK.   +5 more
europepmc   +1 more source

Serum COPA for the diagnosis and immunotherapeutic monitoring of hepatocellular carcinoma: a retrospective study. [PDF]

Front Pharmacol
Cui R, Cao Y, Ren L, Li Y.
europepmc   +1 more source